Terlipressin Administration for Upper GI Bleeding
The recommended dosage of terlipressin for upper GI bleeding is 2 mg IV every 4 hours for the first 48 hours, followed by 1 mg IV every 4 hours for a total treatment duration of 2-5 days. 1, 2, 3
Initial Management and Dosing
- Terlipressin should be initiated as soon as variceal bleeding is suspected, even before endoscopic confirmation 1, 2, 4
- Initial dose: 2 mg IV every 4 hours for the first 48 hours until bleeding is controlled 1, 3
- Maintenance dose: 1 mg IV every 4 hours for a total treatment duration of 2-5 days 1, 3
- Treatment should be administered for 3-5 days to prevent early rebleeding 1
Efficacy and Mechanism
- Terlipressin is the only vasoactive drug proven to reduce bleeding-related mortality (relative risk 0.66,95% CI 0.49-0.88) compared to placebo 2, 4
- Terlipressin reduces portal pressure by decreasing splanchnic blood flow 2, 5
- Initial hemostasis rates with terlipressin are high, with studies showing control of bleeding in 88-98% of cases 6, 7
Alternative Administration Methods
- Recent evidence suggests that continuous infusion of terlipressin (4 mg/24h) may be more effective than bolus administration in reducing portal pressure, with fewer adverse events and at a lower total daily dose 5
- Continuous infusion resulted in significantly higher hepatic venous pressure gradient response at 24 hours compared to bolus dosing (85.4% vs. 58.2%, p=0.002) 5
Duration of Therapy
- Standard duration is 2-5 days 1, 2
- Some studies suggest shorter courses may be effective:
- However, current guidelines still recommend 2-5 days of treatment 1, 3
Combination with Other Treatments
- Terlipressin should be used in combination with:
- Endoscopic therapy (preferably endoscopic variceal band ligation) which should be performed within 12 hours of admission 1, 2
- Antibiotic prophylaxis (ceftriaxone 1g/24h or norfloxacin 400mg twice daily) for up to 7 days 1, 2
- Volume replacement with crystalloids to maintain hemodynamic stability 1
- Restrictive transfusion strategy with a hemoglobin threshold of 7 g/dl and a target of 7-9 g/dl 1
Adverse Effects and Precautions
- Common adverse events include abdominal pain, chest pain, diarrhea, and hyponatremia 1, 4
- Terlipressin has more adverse events compared to octreotide or somatostatin 1
- Consider octreotide in patients with cardiac conditions due to fewer cardiovascular side effects 2
- Avoid nephrotoxic drugs, large volume paracentesis, beta-blockers, vasodilators, and other hypotensive drugs during the course of acute variceal hemorrhage 1
Special Considerations
- For high-risk patients (Child-Pugh class C with score <14 or Child-Pugh class B with active bleeding), early pre-emptive TIPS (within 24-72h) should be considered 1, 2
- In case of uncontrolled bleeding despite terlipressin and endoscopic therapy, rescue TIPS should be used 1
- Balloon tamponade should only be used as a temporary "bridge" (maximum 24 hours) until definitive treatment can be instituted 1